Chacón-Mora Natalia, Pachón Díaz Jerónimo, Cordero Matía Elisa
Servicio de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Del Rocío/cSIC/Universidad de Sevilla, Sevilla, Spain.
Servicio de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Del Rocío/cSIC/Universidad de Sevilla, Sevilla, Spain.
Enferm Infecc Microbiol Clin. 2017 Apr;35(4):255-259. doi: 10.1016/j.eimc.2016.03.003. Epub 2016 Apr 21.
Infectious complications remain a major cause of morbidity and mortality among transplant recipients. Urinary tract infection (UTI) is the most common infectious complication in kidney transplant recipients with a reported incidence from 25% to 75%, varies widely likely due to differences in definition, diagnostic criteria, study design, and length of observation. We sought reviews the incidence and importance of urinary tract infection on graft survival, the microbiology with special emphasis on multidrug resistant microorganisms, the therapeutic management of UTI and the prophylaxis of recurrent UTI among solid organ transplant recipients, highlighting the need for prospective clinical trials to unify the clinical management in this population.
感染性并发症仍然是移植受者发病和死亡的主要原因。尿路感染（UTI）是肾移植受者中最常见的感染性并发症，报告发病率为25%至75%，由于定义、诊断标准、研究设计和观察时间的差异，发病率差异很大。我们旨在综述尿路感染对移植物存活的发生率和重要性、微生物学，特别强调多重耐药微生物、UTI的治疗管理以及实体器官移植受者复发性UTI的预防，强调需要进行前瞻性临床试验以统一该人群的临床管理。
